tiprankstipranks
Trending News
More News >
Community Health (CYH)
NYSE:CYH

Community Health (CYH) AI Stock Analysis

Compare
423 Followers

Top Page

CYH

Community Health

(NYSE:CYH)

Select Model
Select Model
Select Model
Neutral 61 (OpenAI - 4o)
Rating:61Neutral
Price Target:
$3.50
▲(8.02% Upside)
Community Health's overall stock score reflects a mix of positive earnings call outcomes and corporate events, offset by financial risks and neutral technical indicators. The stock's undervaluation is a potential opportunity, but high leverage and negative equity require cautious consideration.
Positive Factors
Leadership Changes
The appointment of experienced leaders as CEO and CFO is expected to drive strategic growth and enhance operational efficiency, providing a stable leadership structure for long-term success.
Revenue Growth
Consistent revenue growth indicates strong market demand and effective pricing strategies, supporting long-term financial health and competitive positioning.
Leverage Reduction
Reducing leverage enhances financial stability and flexibility, allowing the company to invest in growth opportunities and manage economic uncertainties more effectively.
Negative Factors
Negative Revenue Growth
Negative revenue growth can signal declining demand or competitive pressures, potentially impacting long-term profitability and market share.
High Leverage
High leverage and negative equity pose financial risks, limiting the company's ability to invest in growth and increasing vulnerability to economic downturns.
Inflationary Pressures
Inflationary pressures can increase operational costs, squeezing margins and reducing profitability, challenging the company's ability to maintain competitive pricing.

Community Health (CYH) vs. SPDR S&P 500 ETF (SPY)

Community Health Business Overview & Revenue Model

Company DescriptionCommunity Health Systems, Inc. owns, leases, and operates general acute care hospitals in the United States. It offers general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric, and rehabilitation services, as well as skilled nursing and home care services. The company also provides outpatient services at primary care practices, urgent care centers, free-standing emergency departments, ambulatory surgery centers, imaging and diagnostic centers, retail clinics, and direct-to-consumer virtual health visits. As of December 31, 2021, it owned or leased 83 hospitals, including 81 general acute care hospitals and two stand-alone rehabilitation or psychiatric hospitals with an aggregate of 13,289 licensed beds. The company was founded in 1985 and is headquartered in Franklin, Tennessee.
How the Company Makes MoneyCommunity Health generates revenue primarily through patient services, billing for healthcare services provided to patients in its facilities. This includes payments from private insurance, Medicare, and Medicaid for medical treatments, surgeries, and hospital stays. Additionally, CYH earns income from outpatient services, diagnostic testing, and specialized health programs. The company also benefits from partnerships with government health programs and philanthropic organizations that support community health initiatives, as well as grants and funding for specific health programs aimed at enhancing community wellness. These diverse revenue streams help to stabilize the company's financial health while allowing it to reinvest in its facilities and services.

Community Health Earnings Call Summary

Earnings Call Date:Oct 23, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Feb 24, 2026
Earnings Call Sentiment Positive
The earnings call highlighted significant positive developments, such as revenue growth, leverage reduction, and increased employment of physicians. However, challenges were noted in outpatient surgeries, emergency department visits, and inflationary pressures. Despite these challenges, the company remains optimistic about achieving positive cash flow and continued growth.
Q3-2025 Updates
Positive Updates
Same-Store Net Revenue Growth
Same-store net revenue for the third quarter improved by 6% year-over-year, primarily driven by rate growth as net revenue per adjusted admission was up 5.6% year-over-year.
Reduction in Leverage
The company reduced its leverage to 6.7x, down from 7.4x at year-end 2024, and refinanced $1.743 billion of Senior Secured Notes due 2027, pushing out the nearest significant maturity to 2029.
Increase in Employed Physicians and Advanced Practice Providers
The company had approximately 160 more employed physicians and advanced practice providers in clinics as of September 30, 2025, compared to the prior year.
Adjusted EBITDA Growth
Adjusted EBITDA for the third quarter was $376 million, a significant increase from $347 million in the prior year period, with a margin expansion of 100 basis points year-over-year.
Positive Free Cash Flow Expectations
The company remains confident in achieving positive free cash flow for the full year 2025, after adjusting for cash taxes paid on divestiture gains.
Negative Updates
Decline in Outpatient Surgeries
Same-store surgeries declined by 2.2%, and outpatient surgeries showed continued pressure due to consumer demand for elective procedures.
Decline in Emergency Department Visits
Same-store emergency department visits were down by 1.3% year-over-year.
Inflationary Pressures on Costs
Ongoing inflationary pressures and potential incremental upward pressure from tariffs on imported products and raw materials may impact future periods.
Company Guidance
During the Community Health Systems (CHS) third quarter 2025 earnings call, the company updated its financial guidance, tightening its adjusted EBITDA range for the full year to $1.50 billion to $1.55 billion, reflecting consistent operating performance and a $28 million legal settlement gain. Key metrics reported include a 6% year-over-year increase in same-store net revenue, driven by a 5.6% rise in net revenue per adjusted admission, and a 1.3% increase in same-store inpatient admissions. The company successfully reduced its leverage to 6.7x from 7.4x at year-end 2024, following the refinancing of $1.743 billion of Senior Secured Notes due 2027 with $1.79 billion of 2034 notes. CHS also highlighted targeted investments in service line expansions and physician recruitment, with an increase of approximately 160 employed physicians and advanced practice providers as of September 30, 2025. The company remains optimistic about achieving positive free cash flow for the full year, adjusting for cash taxes on divestiture gains.

Community Health Financial Statement Overview

Summary
Community Health's financial performance is mixed. While profitability margins are healthy, the company faces significant financial risks due to high leverage and negative equity. The negative revenue growth trend further complicates the outlook, despite recent improvements in cash flow.
Income Statement
55
Neutral
Community Health's income statement shows mixed results. The TTM data indicates a slight decline in revenue growth at -2.4%, which is concerning. However, the company maintains a positive gross profit margin of 53.12% and a modest net profit margin of 2.60%. The EBIT and EBITDA margins are also healthy at 11.36% and 14.89%, respectively. Despite these strengths, the negative revenue growth trend and past losses highlight potential risks.
Balance Sheet
40
Negative
The balance sheet reveals significant challenges, primarily due to negative stockholders' equity, resulting in a negative debt-to-equity ratio. This indicates high leverage and potential financial instability. The return on equity is also negative, reflecting past losses. The equity ratio is not calculable due to negative equity, further emphasizing the company's financial risk.
Cash Flow
60
Neutral
The cash flow statement shows some positive trends, with a 32.30% growth in free cash flow in the TTM period. The operating cash flow to net income ratio is 0.23, indicating some cash flow generation relative to net income. The free cash flow to net income ratio is 0.61, suggesting that the company is generating cash flow despite past net losses. However, the overall cash flow position remains a concern due to historical volatility.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue12.64B12.63B12.49B12.21B12.37B11.79B
Gross Profit4.29B5.27B5.08B4.91B5.08B4.42B
EBITDA1.40B1.25B1.29B1.17B1.71B1.01B
Net Income329.00M-516.00M-133.00M46.00M230.00M511.00M
Balance Sheet
Total Assets13.24B14.05B14.46B14.67B15.22B16.01B
Cash, Cash Equivalents and Short-Term Investments123.00M37.00M38.00M118.00M507.00M1.68B
Total Debt11.24B12.10B12.17B12.39B12.82B12.88B
Total Liabilities14.19B15.37B15.28B15.40B16.03B17.06B
Stockholders Equity-1.50B-1.91B-1.39B-1.37B-1.37B-1.63B
Cash Flow
Free Cash Flow143.00M120.00M-257.00M-115.00M-600.00M1.74B
Operating Cash Flow493.00M480.00M210.00M300.00M-131.00M2.18B
Investing Cash Flow562.00M-277.00M-22.00M-251.00M-543.00M191.00M
Financing Cash Flow-965.00M-204.00M-268.00M-438.00M-495.00M-909.00M

Community Health Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price3.24
Price Trends
50DMA
3.41
Negative
100DMA
3.11
Positive
200DMA
3.15
Positive
Market Momentum
MACD
-0.02
Positive
RSI
43.42
Neutral
STOCH
7.69
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CYH, the sentiment is Neutral. The current price of 3.24 is below the 20-day moving average (MA) of 3.32, below the 50-day MA of 3.41, and above the 200-day MA of 3.15, indicating a neutral trend. The MACD of -0.02 indicates Positive momentum. The RSI at 43.42 is Neutral, neither overbought nor oversold. The STOCH value of 7.69 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for CYH.

Community Health Risk Analysis

Community Health disclosed 38 risk factors in its most recent earnings report. Community Health reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Community Health Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
$2.09B24.238.58%18.77%6.88%
74
Outperform
$2.09B20.839.94%1.80%23.74%-18.99%
70
Outperform
$1.66B15.355.57%1.62%-22.96%-59.35%
64
Neutral
$10.75B20.1924.94%0.65%11.13%27.53%
61
Neutral
$502.83M1.500.74%
58
Neutral
$1.90B25.0615.48%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CYH
Community Health
3.24
-0.09
-2.70%
ADUS
Addus Homecare
114.59
-15.82
-12.13%
EHC
Encompass Health
107.00
9.90
10.20%
NHC
National Healthcare
138.57
19.14
16.03%
SEM
Select Medical
15.42
-3.87
-20.06%
AVAH
Aveanna Healthcare Holdings
9.02
4.05
81.49%

Community Health Corporate Events

Executive/Board ChangesBusiness Operations and Strategy
Community Health Appoints New CEO and CFO
Positive
Dec 10, 2025

On December 10, 2025, Community Health Systems, Inc. announced the appointment of Kevin J. Hammons as Chief Executive Officer and Jason K. Johnson as Chief Financial Officer, both effective immediately. Hammons, who has been with the company since 1997, previously served as CFO and interim CEO, while Johnson, with the company since 2012, served as interim CFO. These leadership changes are expected to drive the company’s growth and strategic priorities, as both executives bring extensive experience and understanding of the healthcare industry.

M&A TransactionsFinancial Disclosures
Community Health Completes Asset Sale to LabCorp
Neutral
Dec 2, 2025

On December 1, 2025, Community Health Systems, Inc. completed the sale of select assets and leases of its ambulatory outreach business across 13 states to Laboratory Corporation of America Holdings for approximately $194 million in cash. This transaction, which was initially agreed upon in July 2025, represents a significant disposition for the company, impacting its financial statements and operations. The divestiture does not qualify as discontinued operations according to accounting standards, and the pro forma financial statements illustrate the transaction’s impact on the company’s financials as of September 30, 2025.

M&A TransactionsBusiness Operations and Strategy
Community Health Sells Stake in Joint Ventures
Neutral
Oct 31, 2025

On October 30, 2025, Community Health Systems, Inc. announced a definitive agreement to sell its 80% ownership interests in two joint ventures, which own and operate Tennova Healthcare – Clarksville and ancillary businesses, to Vanderbilt University Medical Center for $600 million. This transaction, expected to close in early 2026, is part of the company’s strategic divestitures and involves Vanderbilt purchasing the remaining ownership interests in these ventures. The deal is subject to regulatory approvals and closing conditions, and it highlights Community Health Systems’ ongoing efforts to streamline its operations and focus on core assets.

Private Placements and FinancingM&A TransactionsBusiness Operations and StrategyFinancial Disclosures
Community Health Reports Strong Q3 2025 Financial Results
Positive
Oct 23, 2025

Community Health Systems, Inc. announced its financial results for the third quarter ending September 30, 2025, reporting net operating revenues of $3.087 billion and a net income of $130 million, a significant improvement from the net loss in the same period in 2024. The company completed a refinancing initiative in August 2025, enhancing liquidity and supporting strategic initiatives, and announced divestitures and a definitive agreement with Labcorp to sell select assets, which are expected to impact its financial positioning and operations positively.

Executive/Board ChangesBusiness Operations and Strategy
Community Health CEO Transitions to Consultancy Role
Neutral
Sep 30, 2025

On September 30, 2025, Community Health Systems, Inc. announced that its retiring CEO, Tim L. Hingtgen, has entered into a consultancy agreement with the company. Effective October 1, 2025, Mr. Hingtgen will advise on healthcare operations and strategy until September 30, 2026, receiving a monthly fee while adhering to non-compete and conflict of interest restrictions.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 11, 2025